Viridian Therapeutics, Inc.\DE — Director's Dealing 2021

Jan 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Viridian Therapeutics, Inc.\DE (MGEN)
CIK: 0001590750
Period of Report: 2021-01-15

Reporting Person: Rauch Lee M. (See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-18	Employee Stock Option (right to buy)	$23.03	A	15000	Acquired	2031-01-17	Common Stock (15000)	Direct

Footnotes

F1: The option vests in equal monthly installments over the following 6 months, subject to the Reporting Person's continued service to Issuer through each vesting date.